Geranic acid
Based on 1 Customer Validation
Geranic acid (Geranate) acts as a tyrosinase inhibitor and antifungal agent, with an IC50 value of 0.14-2.3 mM against mushroom tyrosinase. Geranic acid reduces the viability of human pancreatic cancer cells and B-lymphoma cells. Geranic acid inhibits mycelial growth of the maize pathogens Colletotrichum graminicola and Fusarium graminearum. Geranic acid is applicable to research related to fungal infections, pancreatic cancer and B-lymphoma.
For research use only. We do not sell to patients.
- Purity: 90.0%
- CAS No.: 459-80-3
- Formula: C10H16O2
- Molecular Weight:168.23
-
Storage:Pure form -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
Anti-Infection Compound Library
HY-L002
-
Metabolism/Protease Compound Library
HY-L012
-
Natural Product Library
HY-L021
-
Anti-Cancer Compound Library
HY-L025
-
Lipid Compound Library
HY-L043
-
Antifungal Compound Library
HY-L048
-
Medicine Food Homology Compound Library
HY-L055
-
Traditional Chinese Medicine Active Compound Library
HY-L065
-
Anti-Pancreatic Cancer Compound Library
HY-L077
-
Anti-Blood Cancer Compound Library
HY-L079
-
Food Additive Library
HY-L093
-
Anti-Cancer Natural Product Library
HY-L107
-
Plant-Sourced Natural Product Library
HY-L115
-
Metabolic Enzyme Compound Library
HY-L146
-
Anti-Hematopathy Compound Library
HY-L171
-
Multi-Target Compound Library
HY-L176
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Natural Product Library Plus
HY-L021P
-
Natural Product and Natural Product-Like Compound Library
HY-L021M
-
Bioactive Compound Library
HY-L001
-
Miao Ethnicity Medicine Compound Library
HY-L190
-
Flavor Compound Library
HY-L202
-
High-Throughput Bioactive Compound Library
HY-L205
-
High-Throughput Natural Product Library
HY-L206
-
Ancient Chinese Classical Formulas Traditional Chinese Medicine Active Compound Library
HY-L209
-
Antitussive and Antiasthmatic Traditional Chinese Medicine Active Compound Library
HY-L223
-
Diarrhea-Related Traditional Chinese Medicine Active Compound Library
HY-L224
-
Mongolian Medicine Compound Library
HY-L238
-
Flavors and Fragrances Compound Library
HY-L242
-
Natural Product Diversity Scaffold Library
HY-L245
-
Environmental Pollutant Compound Library
HY-L247
Biological Activity
Geranic acid potently inhibits mushroom tyrosinase (trans isomer, IC50 = 0.14 mM), but exerts weak inhibitory activity against mushroom tyrosinase (cis isomer, IC50 = 2.3 mM)[1].
Geranic acid (12.5-400 μM; 72 h) inhibits the viability of human pancreatic cancer cell line MIA PaCa-2, with an IC50 of 263 μM[2].
Geranic acid (12.5-400 μM; 72 h) inhibits the viability of human B lymphoma DeFew cells, with an IC50 of 580 μM[2].
Geranic acid (48 h) inhibits mycelial growth and spore germination of Colletotrichum graminicola (MIC < 7.8 μg/mL, MCIC: 7.8 μg/mL) and Fusarium graminearum (MIC < 7.8 μg/mL, MCIC 31.3 μg/mL)[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:human pancreatic cancer MIA PaCa-2 cells
-
Concentration:12.5, 25M 50, 100, 200, 400 μM
-
Incubation Time:72 h
-
Result:Inhibited MIA PaCa-2 cell viability, with an IC50 value of 263 μM.
-
Cell Line:human B-lymphoma DeFew cells
-
Concentration:12.5, 25M 50, 100, 200, 400 μM
-
Incubation Time:72 h
-
Result:Inhibited DeFew cell viability, with an IC50 value of 580 μM.
Chemical Information
-
CAS No. 459-80-3
-
Appearance Liquid (Density: 0.97 g/cm3)
-
Molecular Weight 168.23
-
Formula C10H16O2
-
Color Colorless to light yellow
-
SMILES
C/C(C)=C/CC/C(C)=C/C(O)=O
-
Synonyms
Geranate; NSC 229335; GAGE
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Pure form -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
DMSO : ≥ 100 mg/mL (594.42 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (14.86 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (14.86 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (270 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Masuda T, et al. Identification of geranic acid, a tyrosinase inhibitor in lemongrass (Cymbopogon citratus). J Agric Food Chem. 2008;56(2):597-601. [Content Brief]
[3]. Yang T, et al. Metabolic engineering of geranic acid in maize to achieve fungal resistance is compromised by novel glycosylation patterns. Metab Eng. 2011;13(4):414-425. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 5.9442 mL | 29.7212 mL | 59.4424 mL | 148.6061 mL |
| 5 mM | 1.1888 mL | 5.9442 mL | 11.8885 mL | 29.7212 mL | |
| 10 mM | 0.5944 mL | 2.9721 mL | 5.9442 mL | 14.8606 mL | |
| 15 mM | 0.3963 mL | 1.9814 mL | 3.9628 mL | 9.9071 mL | |
| 20 mM | 0.2972 mL | 1.4861 mL | 2.9721 mL | 7.4303 mL | |
| 25 mM | 0.2378 mL | 1.1888 mL | 2.3777 mL | 5.9442 mL | |
| 30 mM | 0.1981 mL | 0.9907 mL | 1.9814 mL | 4.9535 mL | |
| 40 mM | 0.1486 mL | 0.7430 mL | 1.4861 mL | 3.7152 mL | |
| 50 mM | 0.1189 mL | 0.5944 mL | 1.1888 mL | 2.9721 mL | |
| 60 mM | 0.0991 mL | 0.4954 mL | 0.9907 mL | 2.4768 mL | |
| 80 mM | 0.0743 mL | 0.3715 mL | 0.7430 mL | 1.8576 mL | |
| 100 mM | 0.0594 mL | 0.2972 mL | 0.5944 mL | 1.4861 mL |
Geranic acid Related Classifications
Cat. No.: HY-W115529
Powered by Bioz
- Geranic acid
- 459-80-3
- Geranate
- NSC 229335
- GAGE
- NSC229335
- NSC 229335
- NSC-229335
- Environmental Pollutants
- Tyrosinase
- Fungal
- DeFew cells
- mushroom tyrosinase
- Fusarium graminearum
- melanogenesis
- melanocytes
- human pancreatic cancer cells
- tyrosinase
- Colletotrichum graminicola
- MIA PaCa-2 cells
- B-lymphoma cells
- Inhibitor
- inhibitor
- inhibit